BOSTON SCIENTIFIC CORP
For the period ended Jun 30, 2026. Filed Aug 3, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 3, 2026
BSX$44.70+1.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Comprehensive Income (Loss) (Unaudited)
| Three Months EndedJune 30, | Six Months EndedJune 30, | |||
|---|---|---|---|---|
| (in millions) | 2026 | 2025 | 2026 | 2025 |
| Net income (loss) | $905 | $795 | $2,243 | $1,467 |
| Other comprehensive income (loss), net of tax: | ||||
| Foreign currency translation adjustment | 84 | (477) | 218 | (691) |
| Net change in derivative financial instruments | 15 | (214) | 93 | (300) |
| Net change in defined benefit pensions and other items | (0) | (0) | 0 | (0) |
| Other comprehensive income (loss) | 98 | (691) | 312 | (991) |
| Comprehensive income (loss) | $1,002 | $104 | $2,555 | $476 |
| Net income (loss) attributable to noncontrolling interests | (2) | (2) | (4) | (4) |
| Other comprehensive income (loss) attributable to noncontrolling interests | 4 | 3 | 7 | 6 |
| Comprehensive income (loss) attributable to noncontrolling interests | 2 | 1 | 3 | 2 |
| Comprehensive income (loss) attributable to Boston Scientific common stockholders | $1,000 | $103 | $2,552 | $474 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.